Effect of clopidogrel on inflammation in atherosclerotic rabbits
Xianghui Kong
Abstract
Xianghui Kong
Abstract
OBJECTIVE To observe the effects of ADP receptor blocker clopidogrel on the levels of serum (hs-CRP) and nuclear factor-kappa B(NF-κB) in atherosclerotic plaque in rabbit models.METHODS Twenty-seven New Zealand male rabbits were randomly divided into normal control group(NC group,n=9),high-cholesterol group(HC group,n=9) and high-cholesterol plus clopidogrel group(HC+C group,n=9) and then were fed for 12 weeks. enzyme-linked immunosorbent assay(ELISA) was employed to monitor the levels of serum hs-CRP and plaque tissue NF-κB in vascular wall,the plaque area of aorta and the neointima thickness were performed with histomorphometry analysis.RESULTS The levels of serum hs-CRP and vascular wall NF-κB p65 subunit, the neointima thickness and plaque area of aorta in the HC group and HC+C group were significantly increased compared with the NC group(P0.05).There was no significantly difference in the serum lipids between the HC group and HC+C group(P0.05),the levels of serum hs-CRP and vascular wall NF-κB p65,the neointima thickness and plaque area of aorta in the HC+C group were significantly decreased compared with the NC group(P0.05).CONCLUSION The study suggested that clopidogel could decrease atherosclerosis and inflammation.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
OBJECTIVE To observe the effects of ADP receptor blocker clopidogrel on the levels of serum (hs-CRP) and nuclear factor-kappa B(NF-κB) in atherosclerotic plaque in rabbit models.METHODS Twenty-seven New Zealand male rabbits were randomly divided into normal control group(NC group,n=9),high-cholesterol group(HC group,n=9) and high-cholesterol plus clopidogrel group(HC+C group,n=9) and then were fed for 12 weeks. enzyme-linked immunosorbent assay(ELISA) was employed to monitor the levels of serum hs-CRP and plaque tissue NF-κB in vascular wall,the plaque area of aorta and the neointima thickness were performed with histomorphometry analysis.RESULTS The levels of serum hs-CRP and vascular wall NF-κB p65 subunit, the neointima thickness and plaque area of aorta in the HC group and HC+C group were significantly increased compared with the NC group(P0.05).There was no significantly difference in the serum lipids between the HC group and HC+C group(P0.05),the levels of serum hs-CRP and vascular wall NF-κB p65,the neointima thickness and plaque area of aorta in the HC+C group were significantly decreased compared with the NC group(P0.05).CONCLUSION The study suggested that clopidogel could decrease atherosclerosis and inflammation.
Key concepts: Neointima, Inflammation, Aorta, Internal medicine, Clopidogrel, Medicine, Group A, Endocrinology